A mouse model of non-motor symptoms in Parkinson’s disease: focus on pharmacological interventions targeting affective dysfunctions
Non-motor symptoms, including psychiatric disorders, are increasingly recognized as a major challenge in the treatment of Parkinson’s disease (PD). These ailments, which often appear in the early stage of the disease, affect a large number of patients and are only partly resolved by conventional ant...
Main Authors: | Alessandra eBonito Oliva, Debora eMasini, Gilberto eFisone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnbeh.2014.00290/full |
Similar Items
-
Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling
by: Gilberto eFisone, et al.
Published: (2011-07-01) -
L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission
by: Michael eFeyder, et al.
Published: (2011-10-01) -
Relationship between smoking and olfactory dysfunction in Parkinson's disease
by: Ming CAO, et al.
Published: (2017-02-01) -
Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology
by: Joanna Wilson, et al.
Published: (2020-10-01) -
Effects of motor imagery training of Parkinson's disease: a protocol for a randomized clinical trial
by: Isaíra Almeida Pereira da Silva Nascimento, et al.
Published: (2019-11-01)